Bengaluru: Aster Hospitals Bangalore, a unit of Aster DM Healthcare has launched an institute of oncology under the banner - Aster International Institute of Oncology (AIIO) today. This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof. The state-of-the-art institute was launched by Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare in the presence of Prof. Dr. Somashekhar S P, Chairman of Medical Advisory Board and Global Director of Aster International Institute of Oncology, Aster DM Healthcare - India & GCC and Dr. Nitish Shetty, Regional Director, Karnataka & Maharashtra, Aster DM Healthcare.

AIIO will provide comprehensive cancer care services to all, which includes Surgical Oncology, Ortho Onco, GynecOnco, Uro-onco, Robotics, SLNB, HIPEC, PIPAC, Breast Oncoplasty, Intraoperative Radiotherpy, MicrovascularAdvanced Plastic Surgery, Lymphoedema Clinic, Medical Oncology, Haematology, Haemato-Oncology, Stem Cell and Bone Marrow, Nuclear Medicine, Nuclear Medicine Therapy center, Oncopathology, Oncogenetics, Pain and Palliative, Hospice Care, Intervention Radiology, Intervention GI, Pulmonology, Nephro, Cardiac, ICU.

Commenting on the need to establish a comprehensive cancer care institute in India, Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare, said “Cancer is emerging as major public health problems in India. On an average, more than 1,300 Indians succumb to the dreadful disease every day. There is a need for specialised infrastructure and expertise in the treatment of cancer. Keeping this in mind, we have launched Aster International Institute of Oncology, which will be spearheaded by Prof. Dr. Somashekhar S P. It is a centre of excellence for Cancer Care and Robotic Surgery, offering the entire range of oncology-related services, backed by an experienced team of doctors, cutting-edge technologies, and the latest innovations in cancer care.”

Speaking on the launch, Prof. Dr. Somashekhar S P, Chairman of Medical Advisory Board and Global Director of Aster International Institute of Oncology, Aster DM Healthcare, India & GCC, said, “The idea is to establish AIIO as the number one cancer care institute in India, and soon to be in the top 5 globally. All centres will have robots, hi-tech dedicated machines, intra-operative radio therapy, state-of-the-art medical equipment. We are also partnering with top universities in the world for the research and development purposes. We are establishing training and fellowship programs in affiliation with Rajiv Gandhi University or any recognized university and offering DrNB Oncology programme. AIIO will be the exclusive research wing and for clinical trials.”

“Based on the cancer registry data, it is estimated that there will be about 8,00,000 new cancer cases in India every year. At any given point, there is likely to be 3 times this load, about 2,40,000 cases. There is an urgent need for utilization of advanced imaging diagnostics, which detect earlier stages of cancer and/or more indolent forms of cancer. With an aim to address this, we are launching Aster International Institute of Oncology. The launch will be in a phase manner. Firstly, we are concentrating in Bangalore, which will cover the whole of Karnataka soon, then Kerala and later spread out to all over India. All centres will be integrated together and will follow the same protocol in the treatment of cancer”, said, Dr. Nitish Shetty, Regional Director - Karnataka & Maharashtra, Aster DM Healthcare. 

Concluding the event, Mr. S Ramesh Kumar, CEO - Aster CMI Hospital, Bangalore, said “We are happy to launch this new oncology institute which is on par with international standards. It will be a great benefit for patients in Bangalore and across the state. We need more institutions like ours to be able to reach out to maximum number of patients.”

About Aster DM Healthcare

Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in GCC and in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary, and quaternary healthcare through our 27 hospitals, 118 clinics, 323 pharmacies and 66 labs & patient experience centres in seven countries, including India. We have over 24,350 plus dedicated staff including 3,110 doctors and 7,063 nurses across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: "We'll treat you well." We reach out to all economic segments in the GCC states through our differentiated healthcare services across the "Aster", "Medcare" and "Access" brands.

Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.

New Delhi (PTI): India's indigenously developed Light Combat Aircraft (LCA-Navy) on Monday landed onboard aircraft carrier INS Vikrant, in a feat described as a historical milestone by the Navy.

The Navy said naval pilots carried out the landing.

"A Historical milestone achieved towards Aatma Nirbhar Bharat by Indian Navy as naval pilots carry out landing of LCA (Navy) onboard INS Vikrant," the Navy said in a brief statement.

It said the landing demonstrated India's capability to design, develop, construct and operate indigenous aircraft carrier with indigenous fighter aircraft.

In September, Prime Minister Narendra Modi commissioned India's first indigenously-built aircraft carrier INS Vikrant (IAC I) that made the country part of an elite group of nations capable of manufacturing aircraft carriers above 40,000 tonnes category.

The Navy had said the aircraft carrier would be able to play a role in ensuring peace and stability in the Indo-Pacific region.